Table 1.
Prediction of positive blocking antibody result at 1 month postvaccination | |||
---|---|---|---|
Variable | OR (95% CI) | P | P adjusted a |
Age (years) | 1.0 (0.96–1.0) | 0.97 | 0.97 |
Sex (M vs. F) | 0.84 (0.34–2.0) | 0.70 | 0.81 |
Vaccine type (mRNA-1273 vs. BNT162b2) | 1.2 (0.48–3.2) | 0.66 | 0.81 |
Prior chemotherapy (Y vs. N) | 1.6 (0.57–4.6) | 0.39 | 0.72 |
Disease status (progressing vs. in remission) | 0.25 (0.08–0.72) | 0.015 | 0.052 |
Time since last anti-CD20 (years) | 1.3 (1.2–1.4) | 3.3 × 10−7 | 2.3 × 10−6 |
NOTE: Multiple logistic regression model for binary outcome of blocking antibody positivity at 1 month postvaccination among patients with lymphoma. See Methods for details.
Abbreviations: CI, confidence interval; F, female; M, male; N, no; OR, odds ratio; Y, yes.
aUsing Benjamini–Hochberg procedure.